NRX Pharmaceuticals, Inc. Warrant
NRXPW
NRXPW
5 hedge funds and large institutions have $3.04K invested in NRX Pharmaceuticals, Inc. Warrant in 2023 Q3 according to their latest regulatory filings, with 3 funds opening new positions, increasing their positions, reducing their positions, and 0 closing their positions.
Holders
5
Holders Change
+3
Holders Change %
+150%
% of All Funds
0.08%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
WAM
1
Wolverine Asset Management
Chicago,
Illinois
|
$995 |
| 2 |
2
UBS Group
Zurich,
Switzerland
|
$625 |
| 3 |
3
Bank of America
Charlotte,
North Carolina
|
$48 |
Top Sellers
No sellers this quarter
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
YCM
1
Yakira Capital Management
Westport,
Connecticut
| $1.37K | 17,129 | – | – |
|
|
WAM
2
Wolverine Asset Management
Chicago,
Illinois
| $995 | 12,426 | +12,426 | New |
|
|
3
UBS Group
Zurich,
Switzerland
| $625 | 7,812 | +7,812 | New |
|
|
4
Bank of America
Charlotte,
North Carolina
| $48 | 600 | +600 | New |
|
|
TRCT
5
Tower Research Capital (TRC)
New York
| $1 | 15 | – | – |
|
|
CFGS
6
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|